Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Cuscutae Semen (CS; Chinese common name “Tusizi”) is one of the most common traditional herbal medicines used to treat liver and kidney diseases in China. Although it is most commonly used as a processed product, little progress has been made on the quality control of CS and salt-processed Cuscutae Semen (PCS). The purpose of this study was to establish a comprehensive strategy integrating chromatographic analysis and chemometric methods for quality evaluation and discrimination of CS and PCS. An accurate and reliable HPLC method was established for the simultaneous quantification of 12 analyte compounds in CS and PCS. The results showed that this method exhibited desirable sensitivity, precision, stability, and repeatability. Multivariate chemometric methods were applied to analyze the obtained HPLC fingerprints, including hierarchical cluster analysis (HCA), principle component analysis (PCA), and partial least squares discriminant analysis (PLS-DA). The results indicated that CS and PCS samples showed a clear classification of the two groups, and three chemical markers with great contributions to the differentiation were screened out. Collectively, the chemometrics combined with the quantitative analysis based on HPLC fingerprint results indicated that salt processing may change the contents and types of components in Cuscutae Semen.

Details

Title
Quality Evaluation of Crude and Salt-Processed Cuscutae Semen through Qualitative and Quantitative Analysis of Multiple Components Using HPLC Combined with Chemometrics
Author
Shi, Yun 1 ; Chang-Li, Xu 2 ; Yu-Jie, Zhu 2 ; Yi-Wen, Tian 2 ; Liu, Xiao 1 ; Gao, Xun 2 ; Kun-Ming Qin 3   VIAFID ORCID Logo  ; Wei-Dong, Li 1 

 Key Laboratory of State Administration of Traditional Chinese Medicine for Standardization of Chinese Medicine Processing, Nanjing University of Chinese Medicine, Nanjing 210046, China 
 Pharmacy School, Jiangsu Ocean University, Lianyungang 222005, China 
 Pharmacy School, Jiangsu Ocean University, Lianyungang 222005, China; Qinghai Xinda Biological Technology Co., Ltd., Xining 810100, China 
First page
231
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
22978739
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2716576609
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.